Abstract
Recently, it was reported that reduction in serum adiponectin levels is correlated with the incidence of breast cancer. As an effort to explain this, we screened various human breast cancer cell lines to identify those in which proliferation is directly controlled by adiponectin. Among the five tested cell lines, proliferation of MDA-MB-231 cancer cell was significantly suppressed by adiponectin within the range of physiological concentration. Furthermore, prolonged adiponectin treatment caused cell growth arrest and even apoptosis of MDA-MB-231. This result is the first to show that adiponectin can directly control cancer cell growth and provides a rationale for the theory that reduction in plasma adiponectin levels could be a risk factor for breast cancer.
Original language | English |
---|---|
Pages (from-to) | 1263-1269 |
Number of pages | 7 |
Journal | Archives of pharmacal research |
Volume | 28 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2005 Nov |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by Konyang University Myung Gok Research Fund of 2004 to Jee Hyun Kang.
Keywords
- Adiponectin
- Apoptosis
- Breast cancer
- Growth arrest
- MDA-MB-231
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery
- Organic Chemistry